Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst / Investor Meet on 24 Nov, 202322-11-2023
22-11-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Change in Directorate
Reappointment of Independent Director for another term of five years by shareholders through postal ballot e-voting20-11-2023
Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer''s Report on postal ballot by voting through remote e-voting20-11-2023
Gland Pharma Ltd - 543245 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Results of voting through postal ballot (remote e-voting) pursuant to Regulation 44(3) of the SEBI LODR, 2015. The resolution for reappointment of Mr. CSN Murthy as an Independent Director and to consider commission on profits as remuneration to him was passed as a special resolution20-11-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor-Group Meeting, in-person, organized by J.P. Morgan on 22 November, 2023 at 14:00 Hrs18-11-2023
Gland Pharma gets USFDA approval to market BP injection, shares down
The Angiotensin II injection is given to raise blood pressure in adults in septic shock15-11-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Gland Pharma receives a tentative approval from the US FDA for Angiotensin II for Injection, 2.5 mg/ml Single-dose vial15-11-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Meeting with Analysts/ Institutional Investors14-11-2023
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
transcript of the Earnings call for Q2FY24 of the Company held on Monday, November 06, 2023, at 18.30 Hrs IST11-11-2023
Buy Gland Pharma; target of Rs 1920: Motilal Oswal
Motilal Oswal is bullish on Gland Pharma recommended buy rating on the stock with a target price of Rs 1920 in its research report dated November 06, 2023.09-11-2023